Effect of the olive leaf extract in chronic spinal cord injury model: an experimental research

• Published in: Annals of medicine and surgery Vol. 85; no. 3; pp. 365 - 381
• Main Authors: Nasution, Iqbal P A, Ibrahim, Sabri, Riawan, Wibi
• Format: Journal Article
• Language: English
• Published: England Lippincott Williams & Wilkins 01-03-2023
• Subjects: Original Research; chronic spinal cord injury; neuroprotective; olive leaf extract
• DOI: 10.1097/MS9.0000000000000085
• EISSN: 2049-0801

Posttraumatic myelopathy is defined as a spinal cord injury (SCI) that results in varying degrees of motor and sensory deficits. The degree of 'secondary damage,' which is caused by a variety of cellular, molecular, and biochemical cascades is linked to the outcome of SCI. According to research, the beneficial effects of oleuropein and its derivatives have been linked to radical scavenging/antioxidant actions and anti-inflammatory effects.
This study was divided into six groups: control negative (sham-operated) group, control positive 1 and 2 (early chronic and chronic), treatment groups 1, 2, and 3 (prophylactic, concomitant, and late). Olive leaf extract (OLE) given dose was 350 mg/kg body weight. Blood was taken from the left corotic artery before the animals were terminated, seromarker assessment, enzyme-linked immunosorbent assay of IL-6, TNF-α, brain-derived neurotrophic factor (BDNF), and assessment of functional motoric outcome before the animal was terminated.
Chronic spinal cord compression increased serum levels of IL-6, TNF-α, and decreased serum level of BDNF. OLE 350 mg/kg body weight decreased serum levels of IL-6, TNF-α and increased functional motoric outcome, especially in prophylactic and concomitant therapy.
These findings indicate that OLE may be effective in protecting chronic SCI model.
Oleuropein has a potential effect to reduce the IL-6 and TNF-α in rabbit model of SCI, and the BDNF value risen after the administration of Oleuropein.